Q4 2024 Earnings Call Transcript March 25, 2025 X4 Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0 ...

Company announcement - No. 7 / 2025 Resolutions from Zealand Pharma's Annual General Meeting 2025 Copenhagen, Denmark, March 27, 2025 - Zealand Pharma A/S ("Zealand") (Nasdaq: ZEAL) (CVR-no. 20045078) ...

Preview: Behind the scenes at New Zealand's Rocket Lab. Some of its rockets are coming to Wallops Island on Virginia's ...

Rocket Lab has launched its workhorse Electron rocket for the third time in two weeks. The New Zealand-based company ...

As of 24 March 2025, Van Herk Investments B.V. (Dutch registration no. 59055057) holds nominally 7,106,191 shares (each share ...

For more on Immunovant’s new data, go here; for more on Sarepta’s gene therapy, go here; to learn more about Zealand’s deal ...

Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, March 20, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a ...

Discover New Zealand’s top advertisers, highest-spending industries, and major market shifts in Nielsen Ad Intel’s 2024 ...

The Pharmaceutical Research and Manufacturers of America, known as PhRMA lodged a formal complaint with President Donald ...

Two of New Zealand’s most successful independent agencies Thompson Spencer and Reason, have announced a landmark merger ...

Two of New Zealand’s independent agencies, Thompson Spencer and Reason, have merged to form one of the largest independent ...

The FTA, expected in two months, aims to boost bilateral trade and cooperation in sectors like agriculture, dairy, and pharmaceuticals.